NasdaqGS - Nasdaq Real Time Price USD

PetMed Express, Inc. (PETS)

Compare
4.5550 -0.0250 (-0.55%)
As of 10:43 AM EST. Market Open.
Loading Chart for PETS
DELL
  • Previous Close 4.5800
  • Open 4.6300
  • Bid 4.5000 x 100
  • Ask 4.6000 x 100
  • Day's Range 4.5250 - 4.6550
  • 52 Week Range 2.9000 - 7.9000
  • Volume 15,770
  • Avg. Volume 247,792
  • Market Cap (intraday) 94.121M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date Feb 6, 2025 - Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 11, 2023
  • 1y Target Est 3.75

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

www.1800petmeds.com

287

Full Time Employees

March 31

Fiscal Year Ends

Recent News: PETS

View More

Performance Overview: PETS

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PETS
39.75%
S&P 500
23.77%

1-Year Return

PETS
41.00%
S&P 500
29.83%

3-Year Return

PETS
82.65%
S&P 500
25.67%

5-Year Return

PETS
76.72%
S&P 500
89.92%

Compare To: PETS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PETS

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    94.64M

  • Enterprise Value

    43.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.37

  • Price/Book (mrq)

    0.98

  • Enterprise Value/Revenue

    0.17

  • Enterprise Value/EBITDA

    8.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.37%

  • Return on Assets (ttm)

    -0.09%

  • Return on Equity (ttm)

    -0.92%

  • Revenue (ttm)

    259.34M

  • Net Income Avi to Common (ttm)

    -963k

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    52.05M

  • Total Debt/Equity (mrq)

    1.26%

  • Levered Free Cash Flow (ttm)

    20.24M

Research Analysis: PETS

View More

Company Insights: PETS

Research Reports: PETS

View More

People Also Watch